Browse studies
Find your next paid study
15 recruiting studies matching your filters
Phase 1
A Phase 1b/2, Single-Arm, Open-Label, Dose-Escalation, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Chiauranib for the Treatment of Advanced Solid Tumors and Relapsed/Refractory SCLC
This is a Phase 1b/2, single-arm, open-label, dose-escalation study including 2 stages: Phase 1b: Dose-Escalation Stage (Single-Dose and Consecutive-Dose Peri…
Small Cell Lung CancerAdvanced Solid Malignant Tumor
Estimated
~$10 – $8,750
Chipscreen Biosciences, Ltd.NCT05271292
Observational
High-resolution Specimen PET-CT Imaging for the Intraoperative Visualization of Resection Margins: an Exploratory Study
Imaging will be exploratory and be used intraoperatively. There have been no discovered risks associated with the device to be used in this study, and none are…
CancerSolid Malignant TumorsSCC - Squamous Cell Carcinoma+2 more
Estimated
~$10 – $6,250
Vanderbilt-Ingram Cancer CenterNCT06915454
A Prospective Diagnostic Cohort Study to Compare the Accuracy of Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for Patients With Clinically Localized Renal Tumors
The goal of this clinical trial is to better tell apart whether kidney tumors are benign (not cancer) or malignant (cancer) based on a biopsy or imaging tests …
Kidney TumorRenal Benign NeoplasmRenal Malignant Tumor
Estimated
~$10 – $750
Loyola UniversityNCT05728957